CClinicalTrials.gg
CompletedNCT04227197DSC2UUpdated Jun 14, 2022Results posted

An Online Health Tool About Down Syndrome: Down Syndrome Clinic to You

An interventional study of Down Syndrome Clinic to You (DSC2U) in Down Syndrome, sponsored by Massachusetts General Hospital. Completed at 1 site in United States. Open to participants aged 1 Year and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-06-14.

Sponsored by Massachusetts General Hospital · Not applicable, Interventional, and Health services research

From the registry’s dates

  • Registered 2 years 3 months after the study started (first participant enrolled Oct 2017, registered Jan 2020).
Phase
Not applicable
Study type
Interventional
Enrollment
281
Allocation
Randomized
Ages
1 Year and older
Sex
All
01

Study summary

The investigators conducted a national two-arm, randomized controlled trial of caregivers of individuals with DS to assess the efficacy of DSC2U in assuring adherence to evidence-based guidelines. The research plan was approved by the Partners Human Research Committee.

Read the detailed description

Background: The overwhelming majority of people with Down syndrome do not have access to specialty clinics, a disparity resulting in delayed or missed diagnoses and significant untreated co-morbidities. To meet this critical gap in needs, the investigators created "Down Syndrome Clinic to You" (DSC2U), a novel, web-based tool created for caregivers of individuals with Down syndrome, which generates personalized recommendations for the caregiver and the patient's primary care provider (PCP).

Methods: In a national, randomized controlled trial of 230 caregivers who had children or dependents with Down syndrome without access to a Down syndrome specialist, 117 were randomized to receive DSC2U and 113 to receive usual-care. The primary outcome was adherence to five health evaluations indicated by national guidelines for Down syndrome: celiac screen, sleep study, thyroid test, audiogram, and ophthalmology evaluation.

02

Conditions studied

  • Down Syndrome

Keywords

  • Online Health Tool
  • Health evaluations
  • Celiac Screen
  • Sleep Study
  • Thyroid Test
  • Audiogram
  • Ophthalmology evaluation
  • Healthcare outcomes survey
  • Experience survey
03

In context

Down Syndrome

432 studies on the registry are indexed under Down Syndrome; 100 are open to participants now.

This study's enrollment of 281 is above the median of 36 across 283 interventional studies indexed under Down Syndrome.

Browse Down Syndrome studies →

Lead sponsor

Massachusetts General Hospital is the lead sponsor of 2,536 studies on the registry; 446 are open to participants now.

Of its 214 completed or terminated interventional studies of FDA-regulated products, 161 (75%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
1 Year and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Potential eligible participants were directed to the study website (www.dsc2u.org) for the eligibility screening questionnaire in English and Spanish and online consent. After selecting a language preference (English or Spanish), in addition to questions about the child's or dependent's biological sex, race and ethnicity, the eligibility screening questions included:

  1. Do you have a child or dependent with DS?
  2. Is your child or dependent 1 year or older?
  3. When is your child's next annual well visit ("PCP visit")?
  4. Does your child or dependent currently receive care at a DS specialty clinic? (If the child or dependent was actively followed in a DS specialty clinic, even one out of state. For example, a family from Arizona who travels to Texas each year for their child to be seen in a DS specialty clinic would be ineligible)

Inclusion criteria

Inclusion Criteria:

  • If you have a child or dependent with Down syndrome (DS)
  • If your child or dependent is 1 year or older
  • If your child or dependent is does not receive care at a DS specialty clinic

Exclusion criteria

Exclusion Criteria:

  • If your child or dependent does receive care at a DS specialty clinic
  • If your child or dependent is under 1 year old
  • If your child or dependent has a PCP that is already involved in the study

DS occurs naturally and proportionally in all races and ethnicities, so the study's population estimates were proportional to the racial/ethnic distribution of the U.S. population, as reported in the 2010 U.S. Census. To achieve commensurate representation in the study, the investigators applied a quota system in offering enrollment using the race and ethnicity of the individual with DS (not the caregiver).

The investigators' plan was to enroll participants such that there were: no more than 144 white individuals with DS, no fewer than 25 Hispanic or Latino/Latina individuals with DS, and no fewer than 20 black individuals with DS. The team also planned to enroll no more than 120 individuals with DS of one sex.

05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
281 participants (actual)

Study arms

  • Experimental
    Intervention Group

    The participants randomized to the intervention group completed the DSC2U questionnaire, and received online access to a personalized Caregiver Checklist and PCP plan. Caregivers were encouraged to share and discuss the PCP plan at their next wellness visit with the PCPs.

    Other: Down Syndrome Clinic to You (DSC2U)

  • No intervention
    Control Group

    The participants randomized to the control group, received usual care for 7 months, after their scheduled PCP appointment. They did not receive DSC2U during these 7 months, but did receive the online, personalized health assessment tool (DSC2U) at the end of the 7 months, after the primary and secondary outcomes were measured.

Interventions

  • OtherDown Syndrome Clinic to You (DSC2U)

    DSC2U is a web-based tool for families to get up-to-date, personalized health and wellness information, based on national guidelines and expert consensus, for a person with Down syndrome.

06

What researchers measure

Primary outcomes

  1. Number of Participants With Indicated Evaluations That Were Completed or Recommended by the PCP

    Adherence to the five health evaluations indicated by national guidelines for Down syndrome. The five health evaluations included: celiac screen, sleep study, thyroid test, audiogram, and ophthalmology evaluation.

    Time frame: 7 months after the participant's scheduled PCP visit

Secondary outcomes

  1. Questionnaire: Caregiver Experience With the Intervention

    Measure the caregiver experience with the PCP using a 10-point Likert scale with "10" representing "most helpful" and "0" representing "least helpful." This questionnaire was only distributed to those in the Intervention arm because it assessed their experience with the Intervention itself.

    Time frame: 2 weeks and 7 months after their scheduled PCP visit and with the intervention

  2. Quality of Life Outcomes for Person With Down Syndrome: 2-week Follow-up

    PedsQL 4.0 parent-proxy and PedsQL 2.0 Family Impact Module (https://www.pedsql.org/) were used to assess for qualify of life for people with Down syndrome and their caregivers. Here we report the change from baseline on the subdomains of these assessments. The subdomains on PedsQL 4.0 parent proxy were Psychosocial and Physical. The subdomains on the Family Impact Module (FIM) were Parental and Family scores. For both instruments we also report the total/summary scores. PedsQL scoring instructions were used. These are all scaled from 0 (Low) to 100 (High). Higher scores indicate a better quality of life. Baseline: (Mean±SD); Change: (Mean±SE)

    Time frame: Change from baseline at the 2-week follow-up time point

  3. Quality of Life Outcomes for Person With Down Syndrome: 7-month Follow-up

    PedsQL 4.0 parent-proxy and PedsQL 2.0 Family Impact Module (https://www.pedsql.org/) were used to assess for qualify of life for people with Down syndrome and their caregivers. Here we report the change from baseline on the subdomains of these assessments. The subdomains on PedsQL 4.0 parent proxy were Psychosocial and Physical. The subdomains on the Family Impact Module (FIM) were Parental and Family scores. For both instruments we also report the total/summary scores. PedsQL scoring instructions were used. These are all scaled from 0 (Low) to 100 (High). Higher scores indicate a better quality of life. Baseline: (Mean±SD); Change: (Mean±SE)

    Time frame: 7-month follow-up survey

  4. PCP Experience With the Intervention (Down Syndrome Clinic to You)

    These measurements were gathered by self-administered mail survey to the PCPs who had patients participating in the Intervention Group. A total of 94 PCPs who had patients in the Intervention Arm responded to this question: "Did \[name\]'s caregiver give you a copy of the primary care plan before and/or during the wellness visit?" (Note: this survey was not mailed to the PCPs who had patients participating in the Control group as the survey was a measure of experience with the Intervention itself.)

    Time frame: 2 weeks after the scheduled PCP visit

07

Results

Posted Jun 14, 2022
Limitations and caveats
We know that Down syndrome naturally occurs equally in all races and ethnicities, regardless of socioeconomic status. We were unable to achieve our targeted enrollment goal for black participants.

Participant flow

Participants were recruited through online social media postings from MassGeneral Hospital and Down syndrome (DS) non-profit organizations around the U.S. The recruitment period started on October 3, 2017 and end on September 30, 2018. Additional recruitment measures were implemented to enroll a demographically diverse sample. These included contacting minority working groups of DS organizations and translated all recruitment materials in Spanish.

Randomization
Participant flow — Randomization
MilestoneIntervention GroupControl Group
Started117113
Completed115113
Not completed20
Withdrew: Protocol violation10
Withdrew: Discontinued participation because uncomfortable sharing information10
Primary Care Provider (PCP) Visit
Participant flow — Primary Care Provider (PCP) Visit
MilestoneIntervention GroupControl Group
Started115113
Completed113113
Not completed20
Withdrew: Did not complete pcp visit20
2-week Follow-up Survey for Caregivers
Participant flow — 2-week Follow-up Survey for Caregivers
MilestoneIntervention GroupControl Group
Started113113
Completed101108
Not completed125
Withdrew: Not responsive75
Withdrew: Lost to follow-up50
2-week Follow-up Survey for PCP's
Participant flow — 2-week Follow-up Survey for PCP's
MilestoneIntervention GroupControl Group
Started114113
Completed9488
Not completed2025
Withdrew: Not responsive2025
7-month Follow-up Survey for Caregivers
Participant flow — 7-month Follow-up Survey for Caregivers
MilestoneIntervention GroupControl Group
Started114113
Completed103110
Not completed113
Withdrew: Lost to follow-up113

Outcome measures

PrimaryNumber of Participants With Indicated Evaluations That Were Completed or Recommended by the PCP

Adherence to the five health evaluations indicated by national guidelines for Down syndrome. The five health evaluations included: celiac screen, sleep study, thyroid test, audiogram, and ophthalmology evaluation.

Time frame:
7 months after the participant's scheduled PCP visit
Reported as:
Number · participants
Number of Participants With Indicated Evaluations That Were Completed or Recommended by the PCP
participantsIntervention GroupControl Group
0 indicated evaluations recommend/complete6979
1 indicated evaluations recommend/complete3631
2 indicated evaluations recommend/complete103
3 indicated evaluations recommend/complete20
Statistical analysis
  • Intervention Group vs Control Group · Cochran-Armitage trend test · p = 0.018Two tailed; no continuity correction
SecondaryQuestionnaire: Caregiver Experience With the Intervention

Measure the caregiver experience with the PCP using a 10-point Likert scale with "10" representing "most helpful" and "0" representing "least helpful." This questionnaire was only distributed to those in the Intervention arm because it assessed their experience with the Intervention itself.

Time frame:
2 weeks and 7 months after their scheduled PCP visit and with the intervention
Reported as:
Count of participants · Participants
Questionnaire: Caregiver Experience With the Intervention
Participants2-week Follow-up Survey for Caregivers in Intervention Arm7-month Follow-up Survey for Caregivers in Intervention Arm
Did you have any problems viewing, downloading, or printing the Caregiver Checklist? — No910
Did you have any problems viewing, downloading, or printing the Caregiver Checklist? — Yes, somewhat50
Did you have any problems viewing, downloading, or printing the Caregiver Checklist? — Yes, definitely50
Did the caregiver checklist explain the recommendations in a way that was easy for you to understand — No30
Did the caregiver checklist explain the recommendations in a way that was easy for you to understand — Yes, somewhat110
Did the caregiver checklist explain the recommendations in a way that was easy for you to understand — Yes, definitely870
Did you use the links to information that were included in the Caregiver Checklist? — No240
Did you use the links to information that were included in the Caregiver Checklist? — Yes, somewhat390
Did you use the links to information that were included in the Caregiver Checklist? — Yes, definitely380
Did you discuss the Caregiver Checklist or any of the recommendations with the [name]? — No580
Did you discuss the Caregiver Checklist or any of the recommendations with the [name]? — Yes, somewhat190
Did you discuss the Caregiver Checklist or any of the recommendations with the [name]? — Yes, definitely240
Would you recommend the Caregiver Checklist to another caregiver? — No01
Would you recommend the Caregiver Checklist to another caregiver? — Yes, somewhat1726
Would you recommend the Caregiver Checklist to another caregiver? — Yes, definitely8476
SecondaryQuality of Life Outcomes for Person With Down Syndrome: 2-week Follow-up

PedsQL 4.0 parent-proxy and PedsQL 2.0 Family Impact Module (https://www.pedsql.org/) were used to assess for qualify of life for people with Down syndrome and their caregivers. Here we report the change from baseline on the subdomains of these assessments. The subdomains on PedsQL 4.0 parent proxy were Psychosocial and Physical. The subdomains on the Family Impact Module (FIM) were Parental and Family scores. For both instruments we also report the total/summary scores. PedsQL scoring instructions were used. These are all scaled from 0 (Low) to 100 (High). Higher scores indicate a better quality of life. Baseline: (Mean±SD); Change: (Mean±SE)

Time frame:
Change from baseline at the 2-week follow-up time point
Reported as:
Mean · score on a scale
Quality of Life Outcomes for Person With Down Syndrome: 2-week Follow-up
score on a scaleIntervention GroupControl Group
baseline score on PedsQL Psychosocial Health Score69.8 ± 14.771.2 ± 13.3
Change from baseline at 2 weeks on PedsQL Psychosocial Health Score-3.2 ± 1.0-2.3 ± 0.9
baseline score on PedsQL Physical63.4 ± 25.462.9 ± 28.6
change from baseline score at 2 weeks on PedsQL Physical Functioning Score-0.2 ± 1.9-0.8 ± 1.9
baseline score on PedsQL Total Scale67.7 ± 13.668.4 ± 15.5
change from baseline score at 2 weeks on PedsQL Total Scale Score-2.0 ± 1.1-1.6 ± 1.0
baseline score for PedsQL FIM Parental68.6 ± 18.267.4 ± 19.6
change in baseline score at 2 weeks on PedsQL FIM Parental HRQL Summary Score-2.4 ± 1.3-2.3 ± 1.2
baseline score on PedsQL FIM Family66.2 ± 20.765.2 ± 24.6
change in baseline score at 2 weeks for PedsQL FIM Family Functioning Summary Score-0.8 ± 1.5-1.8 ± 1.5
baseline score for PedsQL FIM Total Scale Score65.8 ± 17.664.9 ± 20.3
change in baseline score for PedsQL FIM Total Scale Score-0.7 ± 1.1-1.8 ± 1.1
Statistical analysis
  • Intervention Group vs Control Group · ANOVA · p = 0.468
  • Intervention Group vs Control Group · ANOVA · p = 0.802
  • Intervention Group vs Control Group · ANOVA · p = 0.761
  • Intervention Group vs Control Group · ANOVA · p = 0.965
  • Intervention Group vs Control Group · ANOVA · p = 0.619
  • Intervention Group vs Control Group · ANOVA · p = 0.469
SecondaryQuality of Life Outcomes for Person With Down Syndrome: 7-month Follow-up

PedsQL 4.0 parent-proxy and PedsQL 2.0 Family Impact Module (https://www.pedsql.org/) were used to assess for qualify of life for people with Down syndrome and their caregivers. Here we report the change from baseline on the subdomains of these assessments. The subdomains on PedsQL 4.0 parent proxy were Psychosocial and Physical. The subdomains on the Family Impact Module (FIM) were Parental and Family scores. For both instruments we also report the total/summary scores. PedsQL scoring instructions were used. These are all scaled from 0 (Low) to 100 (High). Higher scores indicate a better quality of life. Baseline: (Mean±SD); Change: (Mean±SE)

Time frame:
7-month follow-up survey
Reported as:
Mean · scores on scales
Quality of Life Outcomes for Person With Down Syndrome: 7-month Follow-up
scores on scalesIntervention GroupControl Group
baseline for PedsQL69.8 ± 14.771.2 ± 13.3
Change from baseline for PedsQL Psychosocial Health Score-2.3 ± 1.10.4 ± 1.1
baseline for PedsQL Physical Functioning Score63.4 ± 25.462.9 ± 28.6
Change from baseline for PedsQL Physical Functioning Score6.0 ± 1.96.3 ± 2.5
baseline for PedsQL Total67.7 ± 13.668.4 ± 15.5
Change from baseline for PedsQL Total Scale Score0.6 ± 1.12.5 ± 1.1
baseline for PedsQL FIM Parental HRQL Summary Score68.6 ± 18.267.4 ± 19.6
Change from baseline for PedsQL FIM Parental HRQL Summary Score-4.0 ± 1.3-1.2 ± 1.3
baseline for PedsQL FIM Family Functioning Summary Score66.2 ± 20.765.2 ± 24.6
Change from baseline for PedsQL FIM Family Functioning Summary Score-2.0 ± 1.40.3 ± 1.4
baseline for PedsQL FIM Total Scale Score65.8 ± 17.664.9 ± 20.3
Change from baseline for PedsQL FIM Total Scale Score-2.3 ± 1.1-0.4 ± 1.1
Statistical analysis
  • Intervention Group vs Control Group · ANOVA · p = 0.068
  • Intervention Group vs Control Group · ANOVA · p = 0.907
  • Intervention Group vs Control Group · ANOVA · p = 0.196
  • Intervention Group vs Control Group · ANOVA · p = 0.112
  • Intervention Group vs Control Group · ANOVA · p = 0.245
  • Intervention Group vs Control Group · ANOVA · p = 0.219
SecondaryPCP Experience With the Intervention (Down Syndrome Clinic to You)

These measurements were gathered by self-administered mail survey to the PCPs who had patients participating in the Intervention Group. A total of 94 PCPs who had patients in the Intervention Arm responded to this question: "Did \[name\]'s caregiver give you a copy of the primary care plan before and/or during the wellness visit?" (Note: this survey was not mailed to the PCPs who had patients participating in the Control group as the survey was a measure of experience with the Intervention itself.)

Time frame:
2 weeks after the scheduled PCP visit
Reported as:
Count of participants · Participants
PCP Experience With the Intervention (Down Syndrome Clinic to You)
ParticipantsIntervention Group
No55
Yes, at the visit25
Yes, before the visit11
missing3

Adverse events

Collected over 1 year. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Intervention Group0/117 (0%)0/117 (0%)0/117 (0%)
Control Group0/113 (0%)0/113 (0%)0/113 (0%)

Baseline characteristics

Baseline characteristics of people with Down syndrome

Age, Customized
Age, Customized(Participants)Intervention GroupControl GroupTotal
< 2 years10818
2 to 4 years292857
5 to 7 years171633
8 to 12 years242448
13 to 17 years121123
18 to 25 years131124
26 years or older121527
Sex: Female, Male
Sex: Female, Male(Participants)Intervention GroupControl GroupTotal
Female5452106
Male6361124
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Intervention GroupControl GroupTotal
Hispanic or Latino151328
Not Hispanic or Latino10198199
Unknown or Not Reported123
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Intervention GroupControl GroupTotal
American Indian or Alaska Native101
Asian314
Native Hawaiian or Other Pacific Islander101
Black or African American5712
White101100201
More than one race538
Unknown or Not Reported123
Primary health care insurance
Primary health care insurance(Number of participants)Intervention GroupControl GroupTotal
Public (e.g. Medicaid)322961
Private (e.g. Blue Cross)8483167
None (e.g. self-pay)112
08

Study locations

1 site
  • Massachusetts General Hospital
    Boston, Massachusetts 02114, United States
09

References and documents

Publications

  • Chung J, Sarathy A, Hsieh YG, Estey G, Torres A, Patsiogiannis V, Donelan K, Skotko BG. Assessment of Stakeholder Engagement in a Down Syndrome Research Study. J Patient Cent Res Rev. 2021 Jan 19;8(1):64-67. doi: 10.17294/2330-0698.1777. eCollection 2021 Winter. PubMed 33511255 ↗
  • Chung J, Donelan K, Macklin EA, Schwartz A, Elsharkawi I, Torres A, Hsieh YG, Parker H, Lorenz S, Patsiogiannis V, Santoro SL, Wylie M, Clarke L, Estey G, Baker S, Bauer PE, Bull M, Chicoine B, Cullen S, Frey-Vogel A, Gallagher M, Hasan R, Lamb A, Majewski L, Mast J, Riddell T, Sepucha K, Skavlem M, Skotko BG. A randomized controlled trial of an online health tool about Down syndrome. Genet Med. 2021 Jan;23(1):163-173. doi: 10.1038/s41436-020-00952-7. Epub 2020 Sep 3. Erratum In: Genet Med. 2021 Jan;23(1):236. doi: 10.1038/s41436-020-01033-5. PubMed 32879436 ↗

Study documents

  • Protocol and statistical analysis plan · Feb 28, 2017

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: Yes — The investigators will submit their complete data set to PCORI in accordance with their guidelines.

Supporting information: Study protocol, Sap, Icf, Csr, Analytic code

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 14, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT04227197
Lead sponsor
Massachusetts General Hospital
Collaborators
Patient-Centered Outcomes Research Institute
Responsible party
Brian G Skotko (Director, Down Syndrome Program, Massachusetts General Hospital) — Principal investigator
First posted
Jan 13, 2020
Start date
Oct 3, 2017
Primary completion
May 15, 2019
Completion
May 15, 2019
Results posted
Jun 14, 2022
Last update
Jun 14, 2022

Study contacts

Brian G Skotko, MD, MPP
principal investigator · Massachusetts General Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion